Molecular and cellular basis of genetically inherited skeletal muscle disorders
- PMID: 34257452
- PMCID: PMC9686310
- DOI: 10.1038/s41580-021-00389-z
Molecular and cellular basis of genetically inherited skeletal muscle disorders
Abstract
Neuromuscular disorders comprise a diverse group of human inborn diseases that arise from defects in the structure and/or function of the muscle tissue - encompassing the muscle cells (myofibres) themselves and their extracellular matrix - or muscle fibre innervation. Since the identification in 1987 of the first genetic lesion associated with a neuromuscular disorder - mutations in dystrophin as an underlying cause of Duchenne muscular dystrophy - the field has made tremendous progress in understanding the genetic basis of these diseases, with pathogenic variants in more than 500 genes now identified as underlying causes of neuromuscular disorders. The subset of neuromuscular disorders that affect skeletal muscle are referred to as myopathies or muscular dystrophies, and are due to variants in genes encoding muscle proteins. Many of these proteins provide structural stability to the myofibres or function in regulating sarcolemmal integrity, whereas others are involved in protein turnover, intracellular trafficking, calcium handling and electrical excitability - processes that ensure myofibre resistance to stress and their primary activity in muscle contraction. In this Review, we discuss how defects in muscle proteins give rise to muscle dysfunction, and ultimately to disease, with a focus on pathologies that are most common, best understood and that provide the most insight into muscle biology.
© 2021. Springer Nature Limited.
Conflict of interest statement
Competing interests
1) MJS is a co-founder of a startup called Myogene Bio 2) MJS and CCW serve on the Research Advisory Board for the Muscular Dystrophy Association 3) JMD is the Chief Medical Officer for Deep Genomics
Figures
![Figure 1:](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9686310/bin/nihms-1851556-f0001.gif)
![Figure 2 |](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9686310/bin/nihms-1851556-f0002.gif)
![Figure 3:](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9686310/bin/nihms-1851556-f0003.gif)
![Figure 4 |](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9686310/bin/nihms-1851556-f0004.gif)
![Figure 5 |](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9686310/bin/nihms-1851556-f0005.gif)
![Figure 6 |](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9686310/bin/nihms-1851556-f0006.gif)
Similar articles
-
A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.PLoS One. 2018 Mar 26;13(3):e0194540. doi: 10.1371/journal.pone.0194540. eCollection 2018. PLoS One. 2018. PMID: 29579078 Free PMC article.
-
Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology.Neuromuscul Disord. 2010 Dec;20(12):826-32. doi: 10.1016/j.nmd.2010.08.004. Epub 2010 Sep 17. Neuromuscul Disord. 2010. PMID: 20850317
-
Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres.J Muscle Res Cell Motil. 2006;27(5-7):367-73. doi: 10.1007/s10974-006-9083-4. Epub 2006 Jul 28. J Muscle Res Cell Motil. 2006. PMID: 16874448 Review.
-
Telethonin protein expression in neuromuscular disorders.Biochim Biophys Acta. 2002 Oct 9;1588(1):33-40. doi: 10.1016/s0925-4439(02)00113-8. Biochim Biophys Acta. 2002. PMID: 12379311
-
Animal models for genetic neuromuscular diseases.J Mol Neurosci. 2008 Mar;34(3):241-8. doi: 10.1007/s12031-007-9023-9. Epub 2008 Jan 18. J Mol Neurosci. 2008. PMID: 18202836 Review.
Cited by
-
Identification of novel variations in three cases with rare inherited neuromuscular disorder.Exp Ther Med. 2024 Apr 29;27(6):270. doi: 10.3892/etm.2024.12558. eCollection 2024 Jun. Exp Ther Med. 2024. PMID: 38756899 Free PMC article.
-
Defects in integrin complex formation promote CHKB-mediated muscular dystrophy.Life Sci Alliance. 2024 May 15;7(8):e202301956. doi: 10.26508/lsa.202301956. Print 2024 Aug. Life Sci Alliance. 2024. PMID: 38749543 Free PMC article.
-
Revealing myopathy spectrum: integrating transcriptional and clinical features of human skeletal muscles with varying health conditions.Commun Biol. 2024 Apr 10;7(1):438. doi: 10.1038/s42003-024-06143-3. Commun Biol. 2024. PMID: 38600180 Free PMC article.
-
Collagen type VI regulates TGFβ bioavailability in skeletal muscle.bioRxiv [Preprint]. 2023 Jun 24:2023.06.22.545964. doi: 10.1101/2023.06.22.545964. bioRxiv. 2023. PMID: 38586035 Free PMC article. Preprint.
-
Proteome-scale discovery of protein degradation and stabilization effectors.Nature. 2024 Apr;628(8009):878-886. doi: 10.1038/s41586-024-07224-3. Epub 2024 Mar 20. Nature. 2024. PMID: 38509365
References
-
- Hoffman EP, Brown RH & Kunkel LM Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987. Biotechnology 24, 457–466 (1992). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical